PREVIOUS QUESTION:

 

NEXT QUESTION:

 

How can brentuximab vedotin (Adcetris) help treat Hodgkin's lymphoma?

ANSWER

Brentuximab vedotin (Adcetris) is designed to treat patients whose lymphoma has progressed after treatment with bone marrow stem cell transplantation or those who have had two chemotherapy treatments and are not eligible for transplant.

SOURCES: 

News release, FDA. 

National Cancer Institute. 

National Lymphoma Network.

American Cancer Society.

Reviewed by Laura J. Martin on July 18, 2017

SOURCES: 

News release, FDA. 

National Cancer Institute. 

National Lymphoma Network.

American Cancer Society.

Reviewed by Laura J. Martin on July 18, 2017

NEXT QUESTION:

What are survival rates of Hodgkin's lymphoma?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.

    Other Answers On: